Evidence map›Paper›PMID 34684049›Full record

ArticleMedicina (Kaunas, Lithuania)2021

Turning a Corner in ME/CFS Research.

Derek F H Pheby, Kenneth J Friedman, Modra Murovska, Pawel Zalewski

Open access · goldAbstract readEditorial
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 4 countries.

Derek F H PhebySociety and Health, Buckinghamshire New University, High Wycombe HP11 2JZ, UK.ORCID 0000-0003-1726-0717
Kenneth J FriedmanSchool of Osteopathic Medicine, Rowan University, Stratford, NJ 08080, USA.ORCID 0000-0001-5735-5855
Modra MurovskaInstitute of Microbiology and Virology, Riga Stradiņš University, LV-1067 Riga, Latvia.ORCID 0000-0003-0971-1784
Pawel ZalewskiDepartment of Exercise Physiology and Functional Anatomy, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Swietojanska 20, 85-077 Bydgoszcz, Poland.ORCID 0000-0001-8453-7785
Buckinghamshire New University · GBNicolaus Copernicus University · PLRiga Stradiņš University · LVRowan University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This collection of research papers addresses fundamental questions concerning the nature of myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS), the problem of disbelief and lack of knowledge and understanding of the condition among many doctors and the origins of this problem, and its impact on patients and their families. We report briefly the growing knowledge of the underlying pathological processes in ME/CFS, and the development of new organizations, including Doctors with ME, the US ME/CFS Clinical Coalition and EUROMENE, to address aspects of the challenges posed by the illness. We discuss the implications of COVID-19, which has much in common with ME/CFS, with much overlap of symptoms, and propose a new taxonomic category, which we are terming post-active phase of infection syndromes (PAPIS) to include both. This collection of papers includes a number of papers reporting similar serious impacts on the quality of life of patients and their families in various European countries. The advice of EUROMENE experts on diagnosis and management is included in the collection. We report this in light of guidance from other parts of the world, including the USA and Australia, and in the context of current difficulties in the UK over the promulgation of a revised guideline from the National Institute for Health and Care Excellence (NICE). We also consider evidence on the cost-effectiveness of interventions for ME/CFS, and on the difficulties of determining the costs of care when a high proportion of people with ME/CFS are never diagnosed as such. The Special Issue includes a paper which is a reminder of the importance of a person-centred approach to care by reviewing mind-body interventions. Finally, another paper reviews the scope for prevention in minimizing the population burden of ME/CFS, and concludes that secondary prevention, through early detection and diagnosis, could be of value.

Indexed as

COVID-19Fatigue Syndrome, ChronicEuropeHumansQuality of LifeSARS-CoV-2chronic fatigue syndromeclinical careguidelineknowledge and understandingME/CFSmyalgic encephalomyelitisquality of life

Identifiers

PMID34684049
PMCPMC8541042
OpenAlexW3203879969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.